Biosensors and Nanotechnology for Drug Discovery and Development
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Nanomedicine and Nanobiology".
Deadline for manuscript submissions: closed (31 July 2024) | Viewed by 429
Special Issue Editors
Interests: treatment and diagnosis in cancer; neurological diseases; traumatic brain injury and osteoarthritis; nanotechnology-based drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The drug discovery industry has become such a competitive market that it is constantly challenged to acquire superior drug discovery technologies. Breakthrough forms of biosensors and nanotechnology offer innovative solutions and provide researchers with greater analytical power and higher data quality. In the field of drug discovery and development, the main focus of biosensors and nanotechnology is to enhance diagnostic and assessment methods, and develop improved drug formulations and delivery systems in order to strengthen disease treatment. The field of biosensors and nanotechnology for drug development, delivery, and monitoring has become extremely popular due to the advantages of a short analysis time, high sensitivity, and real-time analysis. However, the application of technology in this area requires further improvement. This Special Issue aims to describe scientific works on biosensors and the latest nanotechnology employed for drug discovery and analysis. Authors are welcome to submit both original articles and reviews.
Dr. Venkatesan Perumal
Dr. Ajay Kumar Yagati
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- nanotechnology
- pharmaceutics
- biosensors
- drug discovery and development
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
